The Company will participate in the Q2FY27 earnings conference call (i.e. post earnings/quarterly call), organized by BNP Paribas Securities India on Wednesday, November 04, 2026 at 09:00 a.m. (IST) to discuss the financial results of the Company for the quarter and half year ended September 30, 2026

Ref: MHL/Sec&Legal/2026-27/54 October 28, 2026 BSE Limited National Stock Exchange of India Limited Scrip Code: 542650 Scrip Symbol: METROPOLIS Dear Sir/Madam, Sub: Intimation of earnings conference call for the quarter and half year ended September 30, 2026 Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Company will participate in the Q2FY27 earnings conference call (i.e. post earnings/quarterly call), organized by BNP Paribas Securities India on Wednesday, November 04, 2026 at 09:00 a.m. (IST) to discuss the financial results of the Company for the quarter and half year ended September 30, 2026 as per details enclosed herewith. We request you to kindly take the above information on record. Thanking you, Yours faithfully, For Metropolis Healthcare Limited Kamlesh C Kulkarni Head – Legal & Secretarial Encl: a/a BNP Paribas Securities India is pleased to invite you to METROPOLIS HEALTHCARE LIMITED – Q2FY2027 Earnings Conference Call Date: Wednesday – 04 November 2026 Time: 09:00am (IST) / 11:30am (HKT, SGT) / 2:30pm (AEDT) / 03:30am (GMT) Management Team: • Ms. Ameera Shah Chairperson & Whole Time Director • Mr. Surendran Chemmenkotil Managing Director • Mr. Sameer Patel Chief Financial Officer • Mr. Mohan Menon Chief Marketing Officer Coordinator: Mr. Tausif Shaikh , Analyst – India Healthcare & Pharmaceuticals , BNP Paribas Securities India Click to join: Link Dial-in details Universal: +91 22 6280 1552 / +91 22 7115 8370 International Toll Free Numbers: Hong Kong : 800 964 448 Singapore : 800 101 2045 Australia : 0 080 014 243444 UK : 0 808 101 1573